


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.32%
+1.99%
+2.67%
+0.07%
GEHC
GE HealthCare Technologie
$84.05
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Investors losing their confidence
GEHC Price Performance
$79.26 (+6.04%)
$79.99 (+5.08%)
$75.48 (+11.35%)
$83.79 (+0.31%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Eps growth
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
GEHC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GEHC Street Sentiment is extremely bullish and have positive views on the near-term outlook
GEHC has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Jan 30, 2026
Reiterate
his Buy
Goldman Sachs
Dec 12, 2025
Reiterate
Buy
Jefferies
Dec 12, 2025
Reiterate
Neutral
Citigroup
Nov 21, 2025
Reiterate
Buy
BTIG
Oct 30, 2025
Reiterate
Overweight
Wells Fargo
What is GEHC current stock price?
What are GEHC stock strengths?
What is GEHC Risk Level?
What is GEHC market cap and volume?
What is GEHC current Stock IQ?
Should I buy GEHC stock right now?
Is GEHC a Strong Buy right now?
What does a 'Strong Buy' rating mean for GEHC?
What does a 'Strong Sell' rating mean for GEHC?
What factors influence GEHC's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
GEHC
GE HealthCare Technologie
Current Price
$84.05

GEHC Price Performance
$79.26 (+6.04%)
$79.99 (+5.08%)
$75.48 (+11.35%)
$83.79 (+0.31%)
GEHC Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Eps growth
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
GEHC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GEHC Street Sentiment is extremely bullish and have positive views on the near-term outlook
GEHC has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
GEHC Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Investors losing their confidence
GEHC Latest Analysis
GE HealthCare Technologies Inc. (GEHC) Positioned to Capitalize on Strong Demand Backlog. GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 5 Patrick Wood from Morgan Stanley lifted the price target on GE HealthCare Technologies Inc. (NASDAQ:GEHC) from $80 to $85 maintaining an Equal Weight rating. The analyst noted the companys fourth-quarter results which [….]
Mon Feb 23, 2026
GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio. GEHC wins FDA clearance for three SIGNA MRI innovations boosting AI-driven workflows sustainability and precision imaging capabilities.
Fri Feb 20, 2026
Whats Going On With GE HealthCare Technologies Stock?. ) shares are up on Friday buoyed by positive sector performance and recent FDA clearances.The FDA has recently approved GE HealthCare’.s next-generation SIGNA MRI technology which is designed to enhance precision imaging and clinical efficiency. This milestone is significant as it includes the SIGNA Sprint with Freelium technology aiming to reduce helium dependency—a critical advancement in making MRI technology more sustainable and cos
Fri Feb 20, 2026
GEHC Expands BARDA Collaboration With $35M Boost for AI Ultrasound. GE HealthCare expands its BARDA deal by $35M to speed AI-enabled ultrasound and next-gen imaging for trauma care and mass casualty readiness.
Wed Feb 18, 2026
Looking Into GE HealthCare Technologies Incs Recent Short Interest. ) short interest as a percent of float has fallen 7.67% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it ris
Tue Feb 17, 2026
GE HealthCare Technologies declares $0.035 dividend.
Fri Feb 13, 2026
GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency. GE HealthCare launches ReadyFix in the United States a remote fleet management tool for MAC VU360 ECGs to boost device uptime and efficiency across hospitals.
Tue Feb 10, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GEHC Stock trends
GEHC Stock performance
GEHC Stock analysis
GEHC investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.